High Tide Inc.

High Tide Inc. operates as a prominent global player in the cannabis retail sector, with business activities spanning Canada, Europe, the United States, and other international markets. The company's portfolio is multifaceted, including the design, manufacturing, and distribution of various smoking accessories and cannabis-inspired lifestyle products. Beyond merchandise, High Tide is actively involved in the wholesale and direct retail of cannabis products, managing and franchising numerous licensed cannabis dispensaries. Furthermore, it offers data analytics services and runs the online retail platforms Grasscity.com and CBDcity.com. As of October 25, 2022, High Tide maintained a substantial retail presence with 149 locations throughout several Canadian provinces, including Ontario, Alberta, British Columbia, Manitoba, and Saskatchewan. Founded in 2009, this Calgary, Canada-based company was rebranded as High Tide Inc. in October 2018, having previously operated under the name High Tide Ventures Inc.

High Tide Inc. trades as HITI.V on TSXV. The company is classified in Healthcare / Medical - Pharmaceuticals and reports in CAD.

The current profile places the business in Medical - Pharmaceuticals. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $593.99M of revenue and -$50.75M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

High Tide Inc. can be compared against peers such as Aurora Cannabis Inc., Cipher Pharmaceuticals Inc., Medical Facilities Corporation, Spectral Medical Inc., Eupraxia Pharmaceuticals Inc., Fennec Pharmaceuticals Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $287.43M, beta of 1.03, and return on equity of -57.9%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

HITI.V currently shows total debt of $149.83M and beta of 1.03. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.hightideinc.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.